Your browser doesn't support javascript.
loading
Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Peng, Wenying; Cao, Liming; Chen, Likun; Lin, Gen; Zhu, Bo; Hu, Xiaohua; Lin, Yingcheng; Zhang, Sheng; Jiang, Meilin; Wang, Jingyi; Li, Junjun; Li, Chao; Shao, Lin; Du, Haiwei; Hou, Ting; Chen, Zhiqiu; Xiang, Jianxing; Pu, Xingxiang; Li, Jia; Xu, Fang; Loong, Herbert; Wu, Lin.
Afiliação
  • Peng W; The Second Department of Thoracic Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
  • Cao L; Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
  • Chen L; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China.
  • Lin G; Department of Thoracic Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
  • Zhu B; Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China.
  • Hu X; The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
  • Lin Y; Cancer Hospital of Shantou University Medical College, Shantou, People's Republic of China.
  • Zhang S; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Jiang M; The Second Department of Thoracic Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
  • Wang J; The Second Department of Thoracic Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
  • Li J; Department of Pathology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
  • Li C; Department of Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, People's Republic of China.
  • Shao L; Burning Rock Biotech, Guangzhou, People's Republic of China.
  • Du H; Burning Rock Biotech, Guangzhou, People's Republic of China.
  • Hou T; Burning Rock Biotech, Guangzhou, People's Republic of China.
  • Chen Z; Burning Rock Biotech, Guangzhou, People's Republic of China.
  • Xiang J; Burning Rock Biotech, Guangzhou, People's Republic of China.
  • Pu X; The Second Department of Thoracic Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
  • Li J; The Second Department of Thoracic Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
  • Xu F; The Second Department of Thoracic Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
  • Loong H; Department of Clinical Oncology, Deputy Medical Director, Phase 1 Clinical Trials Centre, Chinese University of Hong Kong, Hong Kong SAR, People's Republic of China.
  • Wu L; The Second Department of Thoracic Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
Oncologist ; 27(2): e116-e125, 2022 03 04.
Article em En | MEDLINE | ID: mdl-35641209
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumor Carcinoide / Tumores Neuroendócrinos / Tumores Neuroectodérmicos Primitivos / Carcinoma Neuroendócrino / Carcinoma de Células Grandes / Carcinoma Pulmonar de Células não Pequenas / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumor Carcinoide / Tumores Neuroendócrinos / Tumores Neuroectodérmicos Primitivos / Carcinoma Neuroendócrino / Carcinoma de Células Grandes / Carcinoma Pulmonar de Células não Pequenas / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article